Corporate calendar for Incannex Healthcare Limited (IXHL): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA).
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-16 | $-1.99 | $12M |
| 2026-09-16 | $5M | |
| 2026-09-16 | ||
| 2026-09-16 | $-3.22 | $9M |
| 2026-09-16 | ||
| 2026-09-16 | $5M |
Stock Splits
| Date | Ratio |
|---|---|
| 2026-02-27 | 1:30 |
| 2023-11-30 | 1:4 |
Price
| Price | $3.64 |
| Market Cap | $44M |
| Exchange | NASDAQ |
| Country | AU |
Related companies: AGEN · CGTX · IRD · LUCD · SCLX · SEER · STSS
Explore sector: Healthcare · Biotechnology
More sections of IXHL: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks